157 related articles for article (PubMed ID: 9784675)
1. [Comparison of ambulatory and inpatient treatment of acute deep venous thrombosis of the leg: subjective and economic aspects].
Frank D; Blättler W
Schweiz Med Wochenschr; 1998 Sep; 128(36):1328-33. PubMed ID: 9784675
[TBL] [Abstract][Full Text] [Related]
2. [Aspects of cost effectiveness in therapy of acute leg/pelvic vein thrombosis].
Blättler W
Wien Med Wochenschr; 1999; 149(2-4):61-5. PubMed ID: 10454937
[TBL] [Abstract][Full Text] [Related]
3. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR
Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of thromboses with low-molecular-weight heparins].
Haas S; Haas P
Wien Med Wochenschr; 1999; 149(2-4):39-45; discussion 45. PubMed ID: 10378321
[TBL] [Abstract][Full Text] [Related]
5. [Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home].
Osterkorn D; Schramm W; Szucs T
Med Klin (Munich); 1996 Sep; 91(9):607-9. PubMed ID: 8984321
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.
Rodger M; Bredeson C; Wells PS; Beck J; Kearns B; Huebsch LB
CMAJ; 1998 Oct; 159(8):931-8. PubMed ID: 9834718
[TBL] [Abstract][Full Text] [Related]
7. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
Rodger MA; Gagné-Rodger C; Howley HE; Carrier M; Coyle D; Wells PS
Thromb Res; 2003; 112(1-2):13-8. PubMed ID: 15013267
[TBL] [Abstract][Full Text] [Related]
8. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
Brewer D
J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370
[TBL] [Abstract][Full Text] [Related]
9. Outpatient treatment of pulmonary embolism with dalteparin.
Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
[TBL] [Abstract][Full Text] [Related]
10. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression.
Labas P; Ohrádka B; Vladimír J; Cambal M
Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727
[TBL] [Abstract][Full Text] [Related]
11. Cost savings and effectiveness of outpatient treatment with low molecular weight heparin of deep vein thrombosis in a community hospital.
Lee M; Pao D; Hsu T; Sonderskov A
Can J Clin Pharmacol; 2004; 11(1):e17-27. PubMed ID: 15226523
[TBL] [Abstract][Full Text] [Related]
12. [Standard heparin versus low-molecular-weight heparin].
Lockner D
Wien Med Wochenschr; 1999; 149(2-4):37-8. PubMed ID: 10378320
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings.
Hull RD
Thromb Haemost; 2008 Mar; 99(3):502-10. PubMed ID: 18327398
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study.
Santamaría A; Juárez S; Reche A; Gómez-Outes A; Martínez-González J; Fontcuberta J;
Int J Clin Pract; 2006 May; 60(5):518-25. PubMed ID: 16700847
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
16. Outpatient treatment of patients with pulmonary embolism.
Wells PS; Büller HR
Semin Vasc Med; 2001 Nov; 1(2):229-34. PubMed ID: 15199507
[TBL] [Abstract][Full Text] [Related]
17. An outpatient program to treat deep venous thrombosis with low-molecular-weight heparin.
Pearson SD; Blair R; Halpert A; Eddy E; Mckean S
Eff Clin Pract; 1999; 2(5):210-7. PubMed ID: 10623053
[TBL] [Abstract][Full Text] [Related]
18. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.
Huse DM; Cummins G; Taylor DC; Russell MW
Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346
[TBL] [Abstract][Full Text] [Related]
19. Mobilization versus immobilization in the treatment of acute proximal deep venous thrombosis: a prospective, randomized, open, multicentre trial.
Jünger M; Diehm C; Störiko H; Hach-Wunderle V; Heidrich H; Karasch T; Ochs HR; Ranft J; Sannwald GA; Strölin A; Janssen D
Curr Med Res Opin; 2006 Mar; 22(3):593-602. PubMed ID: 16574042
[TBL] [Abstract][Full Text] [Related]
20. Cost comparison of at-home treatment of deep venous thrombosis with low molecular weight heparin to inpatient treatment with unfractionated heparin.
Smith BJ; Weekley JS; Pilotto L; Howe T; Beven R
Intern Med J; 2002; 32(1-2):29-34. PubMed ID: 11783670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
